Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High expression of FLT3 is a risk factor in leukemia
Jie Cheng, Lijun Qu, Jianwen Wang, et al.
Molecular Medicine Reports (2017)
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Gabriele Casirati, Andrea Cosentino, Adele Mucci, et al.
Nature (2023) Vol. 621, Iss. 7978, pp. 404-414
Open Access | Times Cited: 58
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD–Driven Acute Myeloid Leukemia
Stefan Bjelosevic, Emily Gruber, Andrea Newbold, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1582-1599
Open Access | Times Cited: 57
Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology
Lily Yan, Zhen Zhang, Yanfen Liu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 34
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL
Naveen K. Mehta, Martin Pfluegler, Kristan Meetze, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e003882-e003882
Open Access | Times Cited: 31
Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met
Tahereh Damghani, Fatemeh Moosavi, Mehdi Khoshneviszadeh, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia
Christopher Schorr, Fabiana Perna
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML
Maike Roas, Binje Vick, Marc‐André Kasper, et al.
Blood (2022) Vol. 141, Iss. 9, pp. 1023-1035
Open Access | Times Cited: 19
Simultaneous Detection of a Cluster of Differentiation Markers on Leukemia-Derived Exosomes by Multiplex Immuno-Polymerase Chain Reaction via Capillary Electrophoresis Analysis
Netrapal Singh, Lin Huang, Dianbing Wang, et al.
Analytical Chemistry (2020) Vol. 92, Iss. 15, pp. 10569-10577
Closed Access | Times Cited: 29
PRICKLE1, a Wnt/PCP signaling component, is overexpressed and associated with inferior prognosis in acute myeloid leukemia
Duanfeng Jiang, Yanjuan He, Qiuyu Mo, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 22
Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia
Wen Jin, Yuting Dai, Li Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
FLT3‐directed UniCAR T‐cell therapy of acute myeloid leukaemia
Julia Peschke, Ralf Bergmann, M. Mehnert, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 6, pp. 1137-1150
Open Access | Times Cited: 6
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
Sandra Parenti, Sebastiano Rontauroli, Chiara Carretta, et al.
npj Precision Oncology (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 14
FLT3 overexpression in acute leukaemias: New insights into the search for molecular mechanisms
Caroline P. Poubel, Marcela Braga Mansur, Mariana Boroni, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1872, Iss. 1, pp. 80-88
Closed Access | Times Cited: 13
PROTACs: The Future of Leukemia Therapeutics
Zubair Anwar, Muhammad Shahzad Ali, Antonio Galvano, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 8
Lineage tracking to reveal the fate of hematopoietic stem cells influenced by Flk2− multipotent progenitors after transplantation
Zheng Wang, Jiang Du, Mary Vergel-Rodriguez, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 1, pp. 205-214
Open Access | Times Cited: 4
Activated Src kinases downstream of BCR-ABL and Flt3 induces proteasomal degradation of SHIP1 by phosphorylation of tyrosine 1021
Patrick Ehm, Bettina Bettin, Manfred Jücker
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 5, pp. 119467-119467
Open Access | Times Cited: 4
Molecular and clinical significance of FLT3, NPM1, DNMT3A and TP53 mutations in acute myeloid leukemia patients
Ayad M. Ali, Gaza F. Salih
Molecular Biology Reports (2023) Vol. 50, Iss. 10, pp. 8035-8048
Closed Access | Times Cited: 4
Lipopolymer/siRNA complexes engineered for optimal molecular and functional response with chemotherapy in FLT3-mutated acute myeloid leukemia
Aysha Ansari, Cezary Kucharski, K Bahadur, et al.
Acta Biomaterialia (2024) Vol. 188, pp. 297-314
Open Access | Times Cited: 1
FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti‐FLT3 interaction and flow cytometric method
Chadarat Ampasavate, Wasimon Jutapakdee, Rungsinee Phongpradist, et al.
Journal of Clinical Laboratory Analysis (2019) Vol. 33, Iss. 4
Open Access | Times Cited: 10
Risk assessment of FLT3 and PAX5 variants in B-acute lymphoblastic leukemia: a case–control study in a Pakistani cohort
Ammara Khalid, Sara Aslam, Mehboob Ahmed, et al.
PeerJ (2019) Vol. 7, pp. e7195-e7195
Open Access | Times Cited: 9
MiR-455-5p Attenuates Cerebral Ischemic Reperfusion Injury by Targeting FLT3
Jinjing Chen, Chunran Zhu, Weijian Jia, et al.
Journal of Cardiovascular Pharmacology (2020) Vol. 76, Iss. 5, pp. 627-634
Closed Access | Times Cited: 7
FLT3-ITD and CD135 Over-Expression are Frequent Findings of Poor Survival in Adult Patients with Acute Leukemias
Jorge Vela‐Ojeda, Pamela Vazquez Cardenas, Miriam America Garcia-Ruiz Esparza, et al.
Archives of Medical Research (2020) Vol. 52, Iss. 2, pp. 217-223
Closed Access | Times Cited: 7
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients
Selcen Öztürk, Yashna Paul, Saira Afzal, et al.
Leukemia (2021) Vol. 36, Iss. 2, pp. 464-475
Open Access | Times Cited: 7
Infantile B-lymphoblastic leukemia: a case series and review of the literature
Neelum Mansoor, Sadia Imran, Sidra Maqsood, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 4
Open Access | Times Cited: 2
Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia
Yanchun Li, Christopher S. Seet, Ryan Mack, et al.
Stem Cell Reports (2023) Vol. 19, Iss. 1, pp. 100-111
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top